Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.4 USD | +1.42% | -0.04% | +18.48% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.48% | 323B | |
+32.99% | 690B | |
+26.43% | 546B | |
-5.10% | 358B | |
+4.73% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+3.94% | 161B | |
-2.76% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141